Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion type Assertion NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_head.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion description "[Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_provenance.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion evidence source_evidence_literature NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_provenance.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion SIO_000772 15695058 NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_provenance.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion wasDerivedFrom befree-20140225 NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_provenance.
- NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_assertion wasGeneratedBy ECO_0000203 NP475957.RACGSqn0WqHLODu-SRab6tlHQvYs_xTxqwOXEczYG6LW8130_provenance.